Biotech
Gameto
Gameto raises $44M Series C at $250M valuation
$44M
Total Raised
Series C
Latest Round
2020
Founded
60+
Employees
Austin, TX
1 min read
Quick Facts
Valuation
$250M
Latest Round Size
$44M
Latest Round Date
September 2025
Gameto: Series C Funding Round
Gameto has successfully raised $44M in Series C funding, reaching a valuation of $250M.
Company Overview
Stem cell-derived therapies for reproductive health
Funding Details
The Series C round was led by Future Ventures, with participation from Khosla Ventures.
Company Information
- Headquarters: Austin, TX
- Founded: 2020
- Employees: 60+
- Category: Biotech
Investment
Gameto plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Future Ventures: Verified investor in Series C
- Khosla Ventures: Verified investor in Series C
Key Investors
Future Ventures
Lead Investor
Verified investor in Series C
Khosla Ventures
Investor
Verified investor in Series C
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Torl Biotherapeutics
Torl Biotherapeutics raises $96M Series C at $500M valuation
Torl Biotherapeutics raises $96M in Series C at $500M valuation. Antibody-based immunotherapies for cancer patients...
Editorial Team
Oct 10, 2025
1 min read•$96M
Biotech
Nilo Therapeutics
Nilo Therapeutics raises $101M Series A at $450M valuation
Nilo Therapeutics raises $101M in Series A at $450M valuation. Developing therapies based on neuro-immunology research...
Editorial Team
Oct 9, 2025
1 min read•$101M
Biotech
Arthrosi Therapeutics
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
Editorial Team
Oct 8, 2025
1 min read•$153M